---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-100852"
form_type: "8-K"
ticker: "KPRX"
cik: "0001372514"
company_name: "KIORA PHARMACEUTICALS INC"
filed_at: "2022-09-16T23:59:59+00:00"
generated_at: "2026-06-23T09:03:04.193252+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Kiora Pharmaceuticals names Melissa Tosca EVP of Finance; shareholders approve warrant share issuance

## Summary
- Melissa Tosca appointed EVP of Finance effective Sept 13, 2022; will serve as principal accounting and financial officer.
- Tosca receives $300K base salary, target bonus up to 25%, and option to purchase 300,000 shares vesting over 3 years.
- Stockholders approved issuance of up to 60,191,394 shares upon exercise of Class A and B Warrants from July 2022 offering.
- Ratified EisnerAmper as independent auditor for FY2022; adjournment proposal also approved but not needed.

## SEC filing metadata
- accession: 0001104659-22-100852
- form_type: 8-K
- ticker: KPRX
- cik: 0001372514
- company_name: KIORA PHARMACEUTICALS INC
- filed_at: 2022-09-16T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 5.07, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1372514/000110465922100852/0001104659-22-100852-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1372514/000110465922100852/tm2226014d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-100852
- JSON: https://secwatch.observer/filing/0001104659-22-100852.json
- Plain text: https://secwatch.observer/filing/0001104659-22-100852.txt

## Key facts
- Executive change
  Melissa Tosca was appointed as Executive Vice President of Finance at KIORA PHARMACEUTICALS INC.
  - Action: appointed
  - Role: Executive Vice President of Finance
  source text: On September 13, 2022 (the “Effective Date”), Kiora Pharmaceuticals Inc. (the “Company”) appointed Melissa Tosca as Executive Vice President of Finance of the Company, effective as of the Effective Date.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1372514/000110465922100852/0001104659-22-100852-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.